Thank you for supporting life-saving cancer research in Israel.

Please join our end-of-year campaign!

Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ...  Scientific Achievement is in our DNA ... Supporting World-Class Cancer Research in Israel ...  Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ...Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ... Supporting World-Class Cancer Research in Israel ...  Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ...  Supporting World-Class Cancer Research in Israel ... Scientific Achievement is in our DNA ... Supporting World-Class Cancer Research in Israel ...

Apply for a Grant

 

ICRF'S ONLINE APPLICATION SYSTEM
IS NOW OPEN
for the
2019-2020 FUNDING YEAR

The Application Deadline is:  Monday, January 7, 2019

The deadline for Acceleration Grant LOIs is:
November 30, 2018

♦ ♦ ♦ ♦ ♦

Details on the ICRF grant categories that are available for the 2019-2020 funding year are listed below.  Please note that we have a new grant category this year, and that many of the grant stipends and terms have increased.  GOOD LUCK!

Please also note that with the exception of the Barron Scholars' Program, ICRF funds for cancer research are available to citizens of Israel, both native-born and those who have settled.  Funds are not available to visiting scientists.  (Proof of Israeli citizenship must be furnished upon request.) Funds may be requested for clinical or basic research or training, which must relate to cancer and must be conducted in Israel.
 

~ NEW ~

The Immunotherapy Promise, a collaboration between Cancer Research Institute and Israel Cancer Research Fund, will provide funding for qualified scientists at leading universities and research centers throughout Israel with the goal of advancing our understanding of cancer immunotherapy and developing life-extending and saving therapies, novel diagnostic approaches, and/or prevention strategies.  This new funding opportunity is aimed at fostering outstanding basic, pre-clinical, and/or translational research in cancer immunology and immunotherapy throughout Israel. Together, CRI and ICRF will provide a maximum of four grants at a stipend level of $75,000 per year over two (2) years ($150,000 total for each grant).  Awardees will be required to attend the annual CRI-CIMT-EATI-AACR International Immunotherapy Conference at least once during the funding period.  Expenses related to attendance (registration, travel, hotel accommodations, and meals) will be reimbursed up to $5,000 per meeting, over and above the grant stipend.

To View, Save, or Print the Immunotherapy Promise Grant Policies,
click here

 

​"JACKI and BRUCE BARRON
CANCER RESEARCH SCHOLARS’ PROGRAM"

A Partnership Between ICRF and City of Hope, 
generously supported by The Harvey L. Miller Family Foundation

This program has been established to foster outstanding collaborative research and promote the exchange of ideas between exceptional researchers in the United States and Israel.  The overarching goal of this program is to advance our understanding of cancer and develop life-saving therapies, novel diagnostic approaches and/or prevention strategies by leveraging the knowledge and expertise of scientists in the two countries.  The two interrelated components of the program are: 1) collaborative grants to scientists at City of Hope and in Israel that would meet the highest standards of peer-reviewed research.  This grant program will support approximately three grants for two (2) years at a level of $150,000 per year per team ($300,000 total).  The support to the participating institutions will be divided such that 50% of the funds will be designated for the Israeli investigator and institution, and 50% for the City of Hope investigator; 2) an annual symposium that will bring researchers from the United States and Israel together to share research discoveries.  Please download the application packet below.

International Collaboration Grants with City of Hope
►PDF Format     or     MSWord Format

 

​PROJECT GRANTS

These awards are intended to support the research of established investigators. Awards are granted with the understanding that they will support specific projects under the direction of designated principal investigators. Preference is given to persons with more than three years of postdoctoral fellowship or equivalent experience prior to the award commencement date. Awards are made for three (3) years at a maximum stipend of $60,000 per year. (Current Project Grant recipients are encouraged to reapply for continued funding of the same project. Ideally, this should be done during the final year of the award so that, if selected, the new grant will begin upon completion of the old.)

To View, Save, or Print the Project Grant Policies, click here

 

ACCELERATION GRANTS IN CANCER RESEARCH

The Acceleration Grants in Cancer Research are intended to speed up our understanding of the biology underlying cancer and to provide new knowledge that will rapidly enhance the development of innovative therapeutics.  Grant applications responding to this call must propose highly-innovative approaches that have the promise of pioneering new ways of thinking about cancer biology and therapeutics.  Preliminary data are not a prerequisite, but applicants are encouraged to provide data from disparate sources to support the rationale upon which the new concepts are derived.  While not a requirement, grants that utilize interdisciplinary approaches and that are multi-investigator are encouraged.  Of paramount importance, however, is the novelty of the approach and the promise of accelerating progress to a complete mechanistic understanding of cancer, its management and its cure.  ICRF Acceleration Grants are intended to support the research of established investigators.  The grant is made to an institution with the understanding that it will support a specific project under the direction of a designated principal investigator.  ICRF support under this grant category will only be given to Israeli institutions for work in Israel.  Awarded grants will be for a period of two (2) years, with a funding level of $70,000 per year.

In order to apply for the Acceleration Grants Category, a Letter of Intent (LOI) is required. The LOI should be submitted via the online application system by November 30, 2018.

To View, Save, or Print the Acceleration Grant Policies, click here

  

RESEARCH PROFESSORSHIP

This award will be used to support a full-time, senior faculty member, or person in an equivalent position, who has made outstanding contributions to cancer research and who will continue to provide leadership in his or her research area. The applicant must have at least eight years’ experience beyond the doctoral degree, and be no less than five years from the usual and customary age of retirement at his or her institution. Applicants are expected to provide evidence of past accomplishments and, more importantly, demonstrate potential for continued enriching contributions to the cancer research field. The research experience and interest of the applicant may be in either basic biological science or in clinical research and must relate to cancer. The Research Professorship is awarded for a period of seven (7) years at a maximum stipend of $50,000 per year.

To View, Save, or Print the Research Professorship Policies, click here

 

CLINICAL RESEARCH CAREER DEVELOPMENT AWARDS (CRCDAs)

These awards are intended to enhance the clinical research capabilities of young Israeli scientists in the formative phase of their careers who have demonstrated outstanding potential for contribution to clinical cancer research as independent investigators.  Their main purpose is to provide free time for young medical or pediatric oncologists to devote to clinical research projects and to obtain additional (post-fellowship) training to become a leader in clinical research programs. Candidates must have a medical degree and at least two (2) years of fellowship training in medical or pediatric hematology-oncology or a related specialty, but not more than five (5) years of subsequent relevant professional experience prior to the award commencement date. A CRCDA is limited to a single support period of three (3) years at a maximum stipend of $45,000 per year. (Past recipients are not permitted to reapply for this award.)

To View, Save, or Print the CRCDA Policies, click here

 

RESEARCH CAREER DEVELOPMENT AWARDS (RCDAs)

These awards are intended to enhance the research capabilities of young Israeli scientists in the formative phase of their careers who have demonstrated outstanding potential for contribution to cancer research as independent investigators. Candidates must have a doctoral degree, at least three (3) years of postdoctoral fellowship or equivalent experience, and be within five (5) years of their first appointment to an independent position prior to the award commencement date. Awards are made for three (3) years at a maximum stipend of $45,000 per year. (Recipients are permitted and encouraged to reapply once for an additional three years of support, provided that they are still within five years of their first appointment to an independent position prior to the award commencement date.)

To View, Save, or Print the RCDA Policies, click here

 

POSTDOCTORAL FELLOWSHIPS

These awards are intended to support young investigators during their postdoctoral training period. Awards are granted with the understanding that they will support specific projects conducted by recent postdoctoral scientists under the supervision of designated sponsoring senior investigators. Preference is given to persons with no more than three years of postdoctoral fellowship or equivalent experience prior to the award commencement date. Applications are also encouraged from M.D.'s who wish to pursue additional investigative work in a laboratory setting to acquire research experience. Awards are made for three (3) years at a maximum stipend of $30,000 per year.  (Current Postdoctoral Fellowship recipients in the final year of their award desiring continued funding should submit an application for a Project Grant.)

To View, Save, or Print the Postdoctoral Fellowship Policies, click here